{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:34:20Z","timestamp":1757781260361,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["U54 AT008909"],"award-info":[{"award-number":["U54 AT008909"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM011838"],"award-info":[{"award-number":["R01LM011838"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Semant"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13326-018-0183-z","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T13:08:03Z","timestamp":1525871283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extending the DIDEO ontology to include entities from the natural product drug interaction domain of discourse"],"prefix":"10.1186","volume":"9","author":[{"given":"John","family":"Judkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Tay-Sontheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-3856","authenticated-orcid":false,"given":"Mathias","family":"Brochhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"issue":"Web Server issu","key":"183_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/nar\/gkr469","volume":"39","author":"PL Whetzel","year":"2011","unstructured":"Whetzel PL, Noy NF, Shah NH, Alexander PR, Nyulas C, Tudorache T, Musen MA. BioPortal: enhanced functionality via new Web services from the National Center for Biomedical Ontology to access and use ontologies in software applications. Nucleic Acids Res. 2011; 39(Web Server issue):541\u20135.","journal-title":"Nucleic Acids Res"},{"key":"183_CR2","unstructured":"Natural Products Ontology. http:\/\/bioportal.bioontology.org\/ontologies\/NATPRO . Accessed 31 Jan 2018."},{"key":"183_CR3","unstructured":"Batista-Navarro RT, Ananiadou S. Discovering Potential Drugs by Extracting Biological Activities of Natural Products. In: Proceedings of the Workshop on Mining the Pharmacogenomics Literature, Pacific Symposium on Biocomputing, vol. 16: 2011."},{"issue":"4","key":"183_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/AO-2008-0057","volume":"3","author":"E Beisswanger","year":"2008","unstructured":"Beisswanger E, Schulz S, Stenzhorn H, Hahn U. Biotop: An upper domain ontology for the life sciencesa description of its current structure, contents and interfaces to OBO ontologies. Appl Ontol. 2008; 3(4):205\u201312. https:\/\/doi.org\/10.3233\/AO-2008-0057 .","journal-title":"Appl Ontol"},{"issue":"Database issue","key":"183_CR5","first-page":"344","volume":"36","author":"K Degtyarenko","year":"2008","unstructured":"Degtyarenko K, de Matos P, Ennis M, Hastings J, Zbinden M, McNaught A, Alc\u00e1ntara R, Darsow M, Guedj M, Ashburner M. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 2008; 36(Database issue):344\u201350.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"183_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/nar\/gkr972","volume":"40","author":"LM Schriml","year":"2012","unstructured":"Schriml LM, Arze C, Nadendla S, Chang YW, Mazaitis M, Felix V, Feng G, Kibbe WA. Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Res. 2012; 40(Database issue):940\u20136.","journal-title":"Nucleic Acids Res"},{"key":"183_CR7","first-page":"16","volume":"1309","author":"M Brochhausen","year":"2014","unstructured":"Brochhausen M, Schneider J, Malone D, Empey PE, Hogan WR, Boyce RD. Towards a foundational representation of potential drug- drug interaction knowledge. CEUR Workshop Proc. 2014; 1309:16\u201331.","journal-title":"CEUR Workshop Proc"},{"key":"183_CR8","unstructured":"Spyrou C, Lange M. uc_FIDO: Unambiguous Characterization of Food Interactions with Drugs Ontology. CEUR Workshop Proc. 2016;:1747. http:\/\/ceur-ws.org\/Vol-1747\/IP28_ICBO2016.pdf . Accessed 2 May 2018."},{"key":"183_CR9","unstructured":"UC Food Drug Interaction Ontology. https:\/\/github.com\/IC-FOODS\/uc_FoodDrugInteractionOntology . Accessed 2 May 2018."},{"key":"183_CR10","unstructured":"DIDEO Ontology. http:\/\/purl.obolibrary.org\/obo\/DIDEO.owl . Accessed 31 Jan 2018."},{"issue":"11","key":"183_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/nbt1346","volume":"25","author":"B Smith","year":"2017","unstructured":"Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, Goldberg LJ, Eilbeck K, Ireland A, Mungall C, The OBI Consortium, Leontis N, Rocca-Serra P, Ruttenberg A, Sansone S-A, Scheuermann RH, Shah N, Whetzel PL, Lewis S. The OBO Foundry: Coordinated Evolution of Ontologies to Support Biomedical Data Integration. Nat Biotechnol. 2017; 25(11):1251\u20135.","journal-title":"Nat Biotechnol"},{"key":"183_CR12","unstructured":"UW Drug Interaction Database Program. https:\/\/www.druginteractioninfo.org\/ . Accessed 31 Jan 2018."},{"issue":"2","key":"183_CR13","first-page":"173","volume":"109","author":"S Sepp\u00e4l\u00e4","year":"2016","unstructured":"Sepp\u00e4l\u00e4 S, Ruttenberg A, Schreiber Y, Smith B. Definitions in ontologies. Cahiers de Lexicologie. 2016; 109(2):173\u2013207.","journal-title":"Cahiers de Lexicologie"},{"key":"183_CR14","unstructured":"Utecht J, Judkins J, Otte JN, Colvin T, Rogers N, Rose R, Alvi M, Hicks A, Ball J, Bowman SM, Maxson RT, Nabaweesi R, Pradhan R, Sanddal ND, Tudoreanu ME, Winchell RJ, Brochhausen M. OOSTT: a Resource for Analyzing the Organizational Structures of Trauma Centers and Trauma Systems. CEUR Workshop Proc. 2016;:1747. http:\/\/ceur-ws.org\/Vol-1747\/IT504_ICBO2016.pdf . Accessed 2 May 2018."},{"issue":"8","key":"183_CR15","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1101\/gr.180801","volume":"11","author":"M Ashburner","year":"2001","unstructured":"Ashburner M, Ball CA, Blake JA, Butler H, Cherry JM, Eppig JT, Harris M, Hill DP, Mungall C, Reiser L, Rhee S, Richardson JE, Richter J, Ringwald M, Rubin GM, Sherlock G, Yoon J. Creating the Gene Ontology resource: Design and implementation. Genome Res. 2001; 11(8):1425\u201333. https:\/\/doi.org\/10.1101\/gr.180801 .","journal-title":"Genome Res"},{"key":"183_CR16","doi-asserted-by":"publisher","unstructured":"Bandrowski A, Brinkman R, Brochhausen M, Brush MH, Bug B, Chibucos MC, Clancy K, Courtot M, Derom D, Dumontier M, Fan L, Fostel J, Fragoso G, Gibson F, Gonzalez-Beltran A, Haendel MA, He Y, Heiskanen M, Hernandez-Boussard T, Jensen M, Lin Y, Lister AL, Lord P, Malone J, Manduchi E, McGee M, Morrison N, Overton JA, Parkinson H, Peters B, Rocca-Serra P, Ruttenberg A, Sansone SA, Scheuermann RH, Schober D, Smith B, Soldatova LN, Stoeckert CJ, Taylor CF, Torniai C, Turner JA, Vita R, Whetzel PL, Zheng J. The Ontology for biomedical investigations. PLoS ONE. 2016; 11(4). https:\/\/doi.org\/10.1371\/journal.pone.0154556 .","DOI":"10.1371\/journal.pone.0154556"},{"issue":"1","key":"183_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2105-10-125","volume":"10","author":"D Schober","year":"2009","unstructured":"Schober D, Smith B, Lewis SE, Kusnierczyk W, Lomax J, Mungall C, Taylor CF, Rocca-Serra P, Sansone S-A. Survey-based naming conventions for use in OBO Foundry ontology development,. BMC Bioinformatics. 2009; 10(1):125. https:\/\/doi.org\/10.1186\/1471-2105-10-125 .","journal-title":"BMC Bioinformatics"},{"key":"183_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/AO-2011-0087","volume":"6","author":"M Courtot","year":"2011","unstructured":"Courtot M, Gibson F, Lister AL, Malone J, Schober D, Brinkman RR, Ruttenberg A. Mireot: The minimum information to reference an external ontology term. Appl Ontol. 2011; 6:23\u201333.","journal-title":"Appl Ontol"},{"key":"183_CR19","unstructured":"The Potential Drug-drug Interaction and Potential Drug-drug Interaction Evidence Ontology (DIDEO). https:\/\/github.com\/DIDEO\/DIDEO . Accessed 31 Jan 2018."},{"key":"183_CR20","doi-asserted-by":"crossref","unstructured":"Hicks A, Hanna J, Welch D, Brochhausen M, Hogan WR. The ontology of medically related social entities: recent developments. J Biomed Semantics. 2016; 7(47).","DOI":"10.1186\/s13326-016-0087-8"},{"key":"183_CR21","unstructured":"DIDEO Issue Tracker. https:\/\/github.com\/DIDEO\/DIDEO\/issues . Accessed 31 Jan 2018."},{"key":"183_CR22","unstructured":"OWL, 2TL. https:\/\/owl2tl.com . Accessed 31 Jan 2018."},{"key":"183_CR23","unstructured":"NaPDI ATLAS. http:\/\/atlas.napdi.org . Accessed 31 Jan 2018."},{"key":"183_CR24","unstructured":"OHDSI: Observational Health Data Sciences and Informatics. https:\/\/www.ohdsi.org\/ . Accessed 31 Jan 2018."},{"key":"183_CR25","unstructured":"Hanna J, Cheng C, Crow A, Hall R, Liu J, Pendurthi T, Schmidt T, Jennings S, Brochhausen M, Hogan W. Simplifying mireot; a mireot protege plugin. CEUR Workshop Proc. 2012;:914. http:\/\/ceur-ws.org\/Vol-914\/paper_48.pdf . Accessed 2 May 2018."},{"issue":"10","key":"183_CR26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0090-9556(25)08409-0","volume":"24","author":"WG Karam","year":"1996","unstructured":"Karam WG, Goldstein JA, Lasker JM, Ghanayem BI. Human cyp2c19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome p450 enzymes. Drug Metab Dispos. 1996; 24(10):1081\u20137. http:\/\/dmd.aspetjournals.org\/content\/24\/10\/1081.full.pdf .","journal-title":"Drug Metab Dispos"},{"key":"183_CR27","unstructured":"NaPDI Green Tea 19124972 Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea Using a Biochemometric Approach. https:\/\/stage.napdi.org\/study\/24 . Accessed 31 Jan 2018."},{"key":"183_CR28","unstructured":"Annotation Press. https:\/\/dikb.org\/dbmiannotator\/ . Accessed 31 Jan 2018."},{"key":"183_CR29","unstructured":"DIKB Forums. https:\/\/forums.dikb.org\/ . Accessed 31 Jan 2018."}],"container-title":["Journal of Biomedical Semantics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-018-0183-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13326-018-0183-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-018-0183-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:40:48Z","timestamp":1751629248000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsem.biomedcentral.com\/articles\/10.1186\/s13326-018-0183-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/s13326-018-0183-z","relation":{},"ISSN":["2041-1480"],"issn-type":[{"type":"electronic","value":"2041-1480"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"15"}}